
The term restless legs syndrome (RLS) was first introduced by Karl A Ekbom, a Swedish neurologist and surgeon, in 1945, although the earliest description of restless legs associated with sleep disabilities possibly came from Sir Thomas Willis, an English physician, in 1672.1 2 More recently, abnormal involuntary movements during sleep such as nocturnal myoclonus (subsequently termed periodic limb movements during sleep (PLMS)) have been reported to be associated with RLS.3 4
Europe, Cabergoline, Apomorphine, Tetrahydronaphthalenes, Restless Legs Syndrome, 616, Dopamine Agonists, 610, Humans, Thiophenes, Ergolines
Europe, Cabergoline, Apomorphine, Tetrahydronaphthalenes, Restless Legs Syndrome, 616, Dopamine Agonists, 610, Humans, Thiophenes, Ergolines
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 64 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
